SPC227
Emicizumab
Status:
VeittApplication date:
24.5.2018Application published:
15.6.2018Grant published:
15.11.2019
Max expiry date:
26.8.2033Medicine name:
HemlibraMedicine for children:
Yes
Timeline
Today
24.5.2018Application
15.6.2018Publication
15.11.2019Registration
26.8.2033Expires
Marketing license
IS authorization number:
EU/1/18/1271/001-004Date:
2.3.2018
Foreign authorization number:
EU/1/18/1271Date:
23.2.2018
Owner
Name:
Chugai Seiyaku Kabushiki KaishaAddress:
5-1, Ukima 5-chome, Kita-ku Tokyo JP
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221 Hafnarfirði
Patent
Number:
EP2644698
Deadlines
TypeDeadline until
Type: Formgallafrestur, fyrsti
Deadline until: 20.12.2023